Compare · HPQ vs OMCL
HPQ vs OMCL
Side-by-side comparison of HP Inc. (HPQ) and Omnicell Inc. (OMCL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HPQ and OMCL operate in Computer Manufacturing (Technology), so they compete in similar markets.
- HPQ is the larger of the two at $28.61B, about 17.7x OMCL ($1.62B).
- HPQ has hit the wire 6 times in the past 4 weeks while OMCL has been quiet.
- HPQ has more recent analyst coverage (25 ratings vs 24 for OMCL).
- Company
- HP Inc.
- Omnicell Inc.
- Price
- $32.23+1.56%
- $35.22-0.93%
- Market cap
- $28.61B
- $1.62B
- 1M return
- +3.35%
- -
- 1Y return
- +19.26%
- -
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- News (4w)
- 6
- 0
- Recent ratings
- 25
- 24
HP Inc.
HP Inc. provides personal computing and other access devices, imaging and printing products, and related technologies, solutions, and services in the United States and internationally. The company operates through three segments: Personal Systems, Printing, and Corporate Investments. The Personal Systems segment offers commercial and consumer desktop and notebook personal computers, workstations, thin clients, commercial mobility devices, retail point-of-sale systems, displays and other related accessories, software, support, and services. The Printing segment provides consumer and commercial printer hardware, supplies, solutions, and services, as well as scanning devices. The Corporate Investments segment includes HP Labs and business incubation projects. HP Inc. serves individual consumers, small- and medium-sized businesses, and large enterprises, including customers in the government, health, and education sectors. The company was formerly known as Hewlett-Packard Company and changed its name to HP Inc. in October 2015. HP Inc. was founded in 1939 and is headquartered in Palo Alto, California.
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest HPQ
- HP Leads the Expansion of the Local AI Era from GB300 AI Workstations to RTX Spark Windows PCs
- SEC Form 4 filed by HP Inc.
- HP Brings Premium PC Experiences to More Consumers
- HP Googlebook 14 Brings Premium Craftsmanship to Google’s Newest Connected Platform
- HP Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- HP Redefines the Mobile Workstation for the Era of Agentic AI
- RBC Capital Mkts initiated coverage on HP Inc. with a new price target
- HP Extends Data-Center AI Architecture to the Edge
- HP Announces New OmniBook PCs to Help Build the Next Generation of AI Experiences
- Director Francisco Ma. Fatima gifted 24,352 shares and received a gift of 24,352 shares, closing all direct ownership in the company (SEC Form 4)
Latest OMCL
- TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
- Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
- EVP&CHIEF LEGAL/ADMIN OFFICER Manley Corey J covered exercise/tax liability with 4,025 shares, decreasing direct ownership by 4% to 108,985 units (SEC Form 4)
- VP, Chief Accounting Officer Nutt Brian H. covered exercise/tax liability with 937 shares, decreasing direct ownership by 4% to 22,266 units (SEC Form 4)
- President & COO Njoku Nnamdi covered exercise/tax liability with 3,670 shares and sold $113,609 worth of shares (3,083 units at $36.85) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 161,224 units (SEC Form 4)
- CHAIRMAN, CEO Lipps Randall A covered exercise/tax liability with 12,350 shares, decreasing direct ownership by 2% to 511,096 units (SEC Form 4)
- SEC Form 10-Q filed by Omnicell Inc.
- EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
- Omnicell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Omnicell Announces Second Quarter 2026 Financial Results